The NCBI disease corpus (9, 10) is a manually annotated resource for disease name recognition and normalization in biomedical text, which comprises a collection of 793 PubMed abstracts and 6892 disease mentions, which further correspond to 790 disease concepts mapped to MeSH descriptors or OMIM identifiers.
Further outcomes correspond to safety (adverse events and reactions) and toxicity (requiring cessation of treatment) reported throughout the duration of the trial treatment (up to week 48).
Altogether, 41 variants were classified as NC and not further considered (none corresponded to sequence variations defined by Sanger sequencing).
In the clade of i-type genes, three sub-clades were further divided, which corresponded to the TuA3-502, Tuand538 and TuA3-576 genes, accordingly.
In 27 (81%) of these, elevated markers 'flagged' the relapse, and a further 4 markers corresponded to recurrence found at physical examination.
It was shown that relative value of mitochondrial membrane potential measured with tetramethylrhodamine ethyl ester perchlorate (TMRE) probe was lower in resistant cells in comparison with sensitive cells and the drop of mitochondrial potential corresponded to further decrease of resistant cell viability after C60 photoexcitation.
To confirm further that this response corresponded to a reinforcement response, we pretreated cells with the tyrosine phosphatase inhibitor phenylarsine oxide (PAO).[2] When treated cells were subjected to a series of non-homogeneous stretches (Figure S1b), no reinforcement response was observed (Figure 4e).
Further but fewer hits corresponded to the categories 'antibiotic resistance'transcriptionion factor', 'protein toxin' and 'differential gene regulation' with about 0.03 to 0.18% of all reads (Table 6).
Further, decrease/proteolysis of XIAP corresponded with a decrease in inactive procaspase-9, consistent with the ability of intact XIAP to suppress apoptosis by binding procaspase-9 and not allowing enzymatic cleavage to its active form.
From the remaining six plausible mtDNA variants, we determined whether they were causative using the following inclusion criteria for further analysis: (1) cells were viable for further assay, (2) mtDNA variants corresponded to the enzyme assay data in the RC subunit, (3) enzyme deficiency was observed in the fibroblasts, and (4) variants had high heteroplasmy ratios (Fig. 1 and Table 2).
